These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 30373382

  • 21. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis.
    Earley H, Lennon G, Balfe Á, Coffey JC, Winter DC, O'Connell PR.
    Sci Rep; 2019 Oct 30; 9(1):15683. PubMed ID: 31666581
    [Abstract] [Full Text] [Related]

  • 22. The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives.
    Zheng M, Han R, Yuan Y, Xing Y, Zhang W, Sun Z, Liu Y, Li J, Mao T.
    Front Immunol; 2022 Oct 30; 13():1089600. PubMed ID: 36685588
    [Abstract] [Full Text] [Related]

  • 23. Akkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How?
    Geerlings SY, Kostopoulos I, de Vos WM, Belzer C.
    Microorganisms; 2018 Jul 23; 6(3):. PubMed ID: 30041463
    [Abstract] [Full Text] [Related]

  • 24. A review of a potential and promising probiotic candidate-Akkermansia muciniphila.
    Cheng D, Xie MZ.
    J Appl Microbiol; 2021 Jun 23; 130(6):1813-1822. PubMed ID: 33113228
    [Abstract] [Full Text] [Related]

  • 25. Model-driven design of a minimal medium for Akkermansia muciniphila confirms mucus adaptation.
    van der Ark KCH, Aalvink S, Suarez-Diez M, Schaap PJ, de Vos WM, Belzer C.
    Microb Biotechnol; 2018 May 23; 11(3):476-485. PubMed ID: 29377524
    [Abstract] [Full Text] [Related]

  • 26. Akkermansia muciniphila is a promising probiotic.
    Zhang T, Li Q, Cheng L, Buch H, Zhang F.
    Microb Biotechnol; 2019 Nov 23; 12(6):1109-1125. PubMed ID: 31006995
    [Abstract] [Full Text] [Related]

  • 27. Novel pectin-carboxymethylcellulose-based double-layered mucin/chitosan microcomposites successfully protect the next-generation probiotic Akkermansia muciniphila through simulated gastrointestinal transit and alter microbial communities within colonic ex vivo bioreactors.
    Ta LP, Corrigan S, Horniblow RD.
    Int J Pharm; 2024 Nov 15; 665():124670. PubMed ID: 39244071
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases.
    Niu H, Zhou M, Zogona D, Xing Z, Wu T, Chen R, Cui D, Liang F, Xu X.
    Front Immunol; 2024 Nov 15; 15():1370658. PubMed ID: 38571945
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties.
    Pellegrino A, Coppola G, Santopaolo F, Gasbarrini A, Ponziani FR.
    Nutrients; 2023 Apr 08; 15(8):. PubMed ID: 37111034
    [Abstract] [Full Text] [Related]

  • 32. Akkermansia muciniphila and its role in regulating host functions.
    Derrien M, Belzer C, de Vos WM.
    Microb Pathog; 2017 May 08; 106():171-181. PubMed ID: 26875998
    [Abstract] [Full Text] [Related]

  • 33. Cultivation of the Next-Generation Probiotic Akkermansia muciniphila, Methods of Its Safe Delivery to the Intestine, and Factors Contributing to Its Growth In Vivo.
    Ropot AV, Karamzin AM, Sergeyev OV.
    Curr Microbiol; 2020 Aug 08; 77(8):1363-1372. PubMed ID: 32318863
    [Abstract] [Full Text] [Related]

  • 34. Binding of Akkermansia muciniphila to mucin is O-glycan specific.
    Elzinga J, Narimatsu Y, de Haan N, Clausen H, de Vos WM, Tytgat HLP.
    Nat Commun; 2024 May 29; 15(1):4582. PubMed ID: 38811534
    [Abstract] [Full Text] [Related]

  • 35. Novel Gut Microbiota Modulator, Which Markedly Increases Akkermansia muciniphila Occupancy, Ameliorates Experimental Colitis in Rats.
    Nakashima T, Fujii K, Seki T, Aoyama M, Azuma A, Kawasome H.
    Dig Dis Sci; 2022 Jul 29; 67(7):2899-2911. PubMed ID: 34259969
    [Abstract] [Full Text] [Related]

  • 36. In vitro colonisation of the distal colon by Akkermansia muciniphila is largely mucin and pH dependent.
    Van Herreweghen F, Van den Abbeele P, De Mulder T, De Weirdt R, Geirnaert A, Hernandez-Sanabria E, Vilchez-Vargas R, Jauregui R, Pieper DH, Belzer C, De Vos WM, Van de Wiele T.
    Benef Microbes; 2017 Feb 07; 8(1):81-96. PubMed ID: 27824274
    [Abstract] [Full Text] [Related]

  • 37. Mucin degradation niche as a driver of microbiome composition and Akkermansia muciniphila abundance in a dynamic gut model is donor independent.
    Van Herreweghen F, De Paepe K, Roume H, Kerckhof FM, Van de Wiele T.
    FEMS Microbiol Ecol; 2018 Dec 01; 94(12):. PubMed ID: 30239657
    [Abstract] [Full Text] [Related]

  • 38. Nutrient-specific proteomic analysis of the mucin degrading bacterium Akkermansia muciniphila.
    Lee JY, Jin HS, Kim KS, Baek JH, Kim BS, Lee DW.
    Proteomics; 2022 Feb 01; 22(3):e2100125. PubMed ID: 34596327
    [Abstract] [Full Text] [Related]

  • 39. Elucidation of Akkermansia muciniphila Probiotic Traits Driven by Mucin Depletion.
    Shin J, Noh JR, Chang DH, Kim YH, Kim MH, Lee ES, Cho S, Ku BJ, Rhee MS, Kim BC, Lee CH, Cho BK.
    Front Microbiol; 2019 Feb 01; 10():1137. PubMed ID: 31178843
    [Abstract] [Full Text] [Related]

  • 40. The potential of Akkermansia muciniphila in inflammatory bowel disease.
    Zhang T, Ji X, Lu G, Zhang F.
    Appl Microbiol Biotechnol; 2021 Aug 01; 105(14-15):5785-5794. PubMed ID: 34312713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.